Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.
- Conditions
- Bipolar Disorder
- Interventions
- Behavioral: Sleep deprivation and sleep phase advancementOther: usual treatment
- Registration Number
- NCT00229151
- Lead Sponsor
- Norwegian University of Science and Technology
- Brief Summary
The purpose of this study is to determine if sleep deprivation and sleep phase advancement is effective treatment of bipolar patients in a depressive phase.
- Detailed Description
Background: The onset of therapeutic action for most anti-depressive treatments is usually two weeks. During this period patients suffer from great symptomatic distress. Treatment options that are effective in this period is therefore of interest for psychiatric wards.
Aim: To explore if sleep deprivation and three days sleep phase advancement is effective treatment for inpatients with bipolar disorder in a depressive phase.
Method: A randomized controlled trial with 24 patients diagnosed with bipolar disorder. Patients will be randomized to treatment as usual in an psychiatric ward, or sleep deprivation and three days sleep phase advancement. Patients in the treatment as usual group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
- Bipolar disorder, depressive phase
- substance abuse, psychotic symptoms, suicidal intentions, active mania/hypomania.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Sleep deprivation Sleep deprivation and sleep phase advancement Sleep deprivation and sleep phase advancement usual treatment usual treatment -
- Primary Outcome Measures
Name Time Method Scores on rating scales for depression and symptom severity. one month
- Secondary Outcome Measures
Name Time Method Scores on rating scales for anxiety, mania, cognitive processing, and sleep quality. one month
Trial Locations
- Locations (1)
Norwegian University of Science and Technology, Institute of Neuroscience
🇳🇴Trondheim, Norway